<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Characteristics of the COPD and asthma patients</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>Subjects with acute exacerbation of COPD (
     <italic>n</italic> = 402)
    </th>
    <th>Control COPD (
     <italic>n</italic> = 80)
    </th>
    <th>
     <italic>p</italic>-value
     <break/>(compared acute exacerbation and stable COPD)
    </th>
    <th>Subjects with asthma exacerbation of (
     <italic>n</italic> = 100)
    </th>
    <th>Control asthma (
     <italic>n</italic> = 21)
    </th>
    <th>p-value
     <break/>(compared acute and stable asthma)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Gender (Male)</td>
    <td>367 (91.3%)</td>
    <td>78 (97.5%)</td>
    <td>0.03*</td>
    <td>34 (34.0%)</td>
    <td>12 (57.1%)</td>
    <td>0.04*</td>
   </tr>
   <tr>
    <td>Age
     <sup>a</sup>
    </td>
    <td>77.4 ± 8.6</td>
    <td>73.2 ± 7.4</td>
    <td>0.00*</td>
    <td>64.8 ± 17.7</td>
    <td>48.0 ± 14.6</td>
    <td>0.00*</td>
   </tr>
   <tr>
    <td>Influenza vaccination in the last 12 months</td>
    <td>150 (37.3%)</td>
    <td>33 (41.2%)</td>
    <td>0.50</td>
    <td>26 (26.0%)</td>
    <td>2 (9.5%)</td>
    <td>0.15</td>
   </tr>
   <tr>
    <td>Types of residence</td>
    <td/>
    <td/>
    <td>0.00*</td>
    <td/>
    <td/>
    <td>0.12</td>
   </tr>
   <tr>
    <td> Live alone</td>
    <td>39 (9.7%)</td>
    <td>4 (5.0%)</td>
    <td/>
    <td>11 (11.0%)</td>
    <td>0 (0.0%)</td>
    <td/>
   </tr>
   <tr>
    <td> Old age home resident</td>
    <td>42 (10.4%)</td>
    <td>0 (0.0%)</td>
    <td/>
    <td>3 (3.0%)</td>
    <td>0 (0.0%)</td>
    <td/>
   </tr>
   <tr>
    <td> Live with family</td>
    <td>321 (79.9%)</td>
    <td>76 (95.0%)</td>
    <td/>
    <td>86 (86.0%)</td>
    <td>21 (100.0%)</td>
    <td/>
   </tr>
   <tr>
    <td>Current smokers</td>
    <td>68 (16.9%)</td>
    <td>18 (22.5%)</td>
    <td>0.20</td>
    <td>4 (4.0%)</td>
    <td>2 (9.5%)</td>
    <td>0.291</td>
   </tr>
   <tr>
    <td colspan="7">Medications before admission</td>
   </tr>
   <tr>
    <td> any ICS</td>
    <td>317 (78.9%)</td>
    <td>68 (85.0%)</td>
    <td>0.14</td>
    <td>76 (76.0%)</td>
    <td>19 (90.5%)</td>
    <td>0.12</td>
   </tr>
   <tr>
    <td> ICS with LABA</td>
    <td>286 (71.1%)</td>
    <td>66 (82.5%)</td>
    <td>0.02*</td>
    <td>65 (65.0%)</td>
    <td>18 (85.7%)</td>
    <td>0.05*</td>
   </tr>
   <tr>
    <td> LABA+LAMA</td>
    <td>199 (49.5%)</td>
    <td>75 (93.8%)</td>
    <td>&lt; 0.001*</td>
    <td>30 (30.0%)</td>
    <td>4 (19.0%)</td>
    <td>0.23</td>
   </tr>
   <tr>
    <td colspan="7">Comorbidities</td>
   </tr>
   <tr>
    <td> Old tuberculosis</td>
    <td>67 (16.6%)</td>
    <td>9 (11.3%)</td>
    <td>0.22</td>
    <td>4 (4.0%)</td>
    <td>0 (0.0%)</td>
    <td>1.00</td>
   </tr>
   <tr>
    <td> Bronchiectasis</td>
    <td>21 (5.2%)</td>
    <td>2 (2.5%)</td>
    <td>0.39</td>
    <td>4 (4.0%)</td>
    <td>0 (0.0%)</td>
    <td>1.00</td>
   </tr>
   <tr>
    <td> Congestive heart Failure</td>
    <td>36 (8.9%)</td>
    <td>4 (5.0%)</td>
    <td>0.24</td>
    <td>9 (9.0%)</td>
    <td>0 (0.0%)</td>
    <td>0.35</td>
   </tr>
   <tr>
    <td> Ischaemic heart disease</td>
    <td>38 (9.4%)</td>
    <td>5 (6.2%)</td>
    <td>0.35</td>
    <td>7 (7.0%)</td>
    <td>1 (4.7%)</td>
    <td>1.00</td>
   </tr>
   <tr>
    <td> Hypertension</td>
    <td>211 (52.4%)</td>
    <td>29 (36.2%)</td>
    <td>0.00*</td>
    <td>39 (39.0%)</td>
    <td>4 (19%)</td>
    <td>0.08</td>
   </tr>
   <tr>
    <td> Hyperlipidaemia</td>
    <td>65 (16.1%)</td>
    <td>9 (11.2%)</td>
    <td>0.26</td>
    <td>17 (17.0%)</td>
    <td>1 (4.7%)</td>
    <td>0.19</td>
   </tr>
   <tr>
    <td> DM</td>
    <td>79 (19.6%)</td>
    <td>12 (15.0%)</td>
    <td>0.33</td>
    <td>19 (19.0%)</td>
    <td>2 (9.5%)</td>
    <td>0.52</td>
   </tr>
   <tr>
    <td> Osteoarthritis</td>
    <td>8 (1.9%)</td>
    <td>2 (2.5%)</td>
    <td>0.67</td>
    <td>4 (4.0%)</td>
    <td>0 (0.0%)</td>
    <td>1.00</td>
   </tr>
   <tr>
    <td>Lung function</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
    <td/>
   </tr>
   <tr>
    <td> Post-brochodilator FEV % predicted (%)
     <sup>a</sup>
    </td>
    <td>45.8 ± 20.5</td>
    <td>46.7 ± 17.6</td>
    <td>0.71</td>
    <td>73.8 ± 20.2</td>
    <td>80.3 ± 22.6</td>
    <td>0.23</td>
   </tr>
   <tr>
    <td> Post-brochodilator FEV1/FVC ratio (%)
     <sup>a</sup>
    </td>
    <td>50.4 ± 15.5</td>
    <td>47.1 ± 12.9</td>
    <td>0.08</td>
    <td>69.1 ± 11.6</td>
    <td>74.9 ± 11.8</td>
    <td>0.06</td>
   </tr>
   <tr>
    <td colspan="7">During Admission</td>
   </tr>
   <tr>
    <td colspan="7"> Symptoms</td>
   </tr>
   <tr>
    <td>  Cough</td>
    <td>347 (86.3%)</td>
    <td/>
    <td/>
    <td>81 (81.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  Wheeze</td>
    <td>192 (47.8%)</td>
    <td/>
    <td/>
    <td>62 (62.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  Fever</td>
    <td>133 (33.1%)</td>
    <td/>
    <td/>
    <td>32 (32.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  Runny nose</td>
    <td>15 (3.7%)</td>
    <td/>
    <td/>
    <td>9 (9.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  SOB</td>
    <td>380 (94.5%)</td>
    <td/>
    <td/>
    <td>88 (88.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  Sputum production</td>
    <td>344 (85.6%)</td>
    <td/>
    <td/>
    <td>74 (74.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  Sore throat</td>
    <td>31 (7.7%)</td>
    <td/>
    <td/>
    <td>18 (18.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  Chest pain</td>
    <td>48 (11.9%)</td>
    <td/>
    <td/>
    <td>9 (9.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>  Hemoptysis</td>
    <td>6 (1.5%)</td>
    <td/>
    <td/>
    <td>1 (1.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Use of Non-invasive positive pressure ventilation</td>
    <td>70 (17.4%)</td>
    <td/>
    <td/>
    <td>5 (5.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Use of invasive mechanical ventilation</td>
    <td>1 (0.2%)</td>
    <td/>
    <td/>
    <td>0 (0.0%)</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>Intensive care admission</td>
    <td>2 (0.5%)</td>
    <td/>
    <td/>
    <td>1 (1.0%)</td>
    <td/>
    <td/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Data are presented as mean ± SD
   <sup>a</sup> or number (percentages)
  </p>
  <p>
   <italic>ICS</italic> inhaled corticosteroid, 
   <italic>LABA</italic> long-acting beta-agonist, 
   <italic>LAMA</italic> long-acting anti-muscurinic agent
  </p>
  <p>* 
   <italic>p</italic> &lt; 0.05
  </p>
 </table-wrap-foot>
</table-wrap>
